Groowe Groowe / Newsroom / IBB
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

IBB News

Molecular Switch Targeting Therapies Market Research Report 2026: Opportunities in Targeted Drug Delivery Systems and Therapies in Oncology, Autoimmune, Inflammatory, and Neurological Disorders

globenewswire.com
MRK BMY AZN PFE NVS LLY GILD JNJ REGN ABBV NVO SNY VRTX AMGN BIIB INCY EXEL SRPT CRSP EDIT NTLA ALNY MRNA BNTX COHR IMUX INSM CYTK KODK LULU NVDA GOOG MSFT IBM AMAT ILMN ALKS ACAD MNKD TEVA BHC XBI IBB XLF XLK XLV JAZZ ACGL

Systemic Lupus Erythematosus Market to Exhibit Growth at a CAGR of 9.4% During the Forecast Period (2025–2034) Owing to Rising Use of Biologics – Approvals of BENLYSTA and SAPHNELO, Plus a Strong Pipeline | DelveInsight

globenewswire.com
JNJ BIIB NVS VTRS RPRX ABBV AZN MRK RIGL GSK REGN GILD AMGN LLY BMY XBI IBB

Psoriasis Market to Exhibit Growth at a CAGR of 1.7% During the Forecast Period (2025-2034), Owing to Continuous Innovation in Biologic Therapies and Approval of Oral Small Molecules | DelveInsight

prnewswire.com
TAK JNJ CANF AMGN ABBV NVS BMY AZN BHC LLY UCB LEO REGN XBI IBB JAZZ MRK SNY GILD INCY PFE LULU PRTH DRH BIIB TEVA ARCT HRMY CRSP NTLA EDIT SNOW DDOG CRM GOOG MSFT AAPL AMZN TSLA NVDA META NFLX DIS CMCSA VZ T KO PEP MCD SBUX HD EXAS ILMN BNTX MRNA XOM CVX BA CAT GE IBM INTC CSCO ADBE QCOM AMAT MU ORCL ACN COST WMT TGT LOW HON GD LMT RTX BAX

Antibody Optimization Service Market Set to Reach USD 6.07 Billion by 2034, Growing at an 8.45% CAGR Amid Advances in Gene-Editing Technologies

globenewswire.com
ABBV BMY GILD AMGN AZN LLY BIIB REGN VRTX XBI IBB CRSP EDIT NTLA ABCL NVS MRK PFE JNJ GSK SNY BTAI INSM

Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

globenewswire.com
AMGN PFE LLY AZN BMY NVS SNY GSK UCB ARQT REGN INCY ABBV BIIB MRK JNJ VNDA RAPT CHAI ONON ION ASMB CRVS APG KSCP KYMR XBI IBB ADSK CDNS SNPS